A. Maniotis, R. Maniotis, 1206 N.J. Espat, X. Chen, P. Lycos/Medical Veritas 3 (2006) 1206–1210 Andrew Maniotisa, PhD; Rita Maniotisb; N. Joseph Espatc, MD; Xue Chend, MD; Peter Lycose, PhD Abstract: Evidence from many sources show the hepatitis B vaccine is not safe or effective, and is linked to many autoimmune syndromes. Hepatitis B syn-drome […]
Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness
Published in the Journal of the Royal Society of Medicine; June 2012 105:229 Authors: I Mattheij,1 AM Pollock,2 P Brhlikova3 Summary The Indian government suspended research in April 2010 on the feasibility and safety of human papillomavirus (HPV) vaccine in two Indian states (Andhra Pradesh and Gujarat) amid public concerns about its safety. This paper describes cervical cancer […]
Public Awareness and Cervical Cancer Screening
By P. Davies Article first published online: 16 MAY 2012 DOI: 10.1111/j.1365-2303.2012.00984.x © 2012 Blackwell Publishing Ltd Population-based, organized screening programmes can reduce cervical cancer rates by 80%,1 although this will only be achieved with high coverage of the target population.2–4 The introduction of vaccines protecting against oncogenic human papillomavirus (HPV) types 16 and 18 has provided a […]
Gardasil and Cervarix: Reasons for Caution Still Exist
[SaneVax: In 2008, Dr. Charlotte Haug urged caution when considering implementation of HPV (human papillomavirus) vaccination programs. Not many people in the medical establishment appeared to listen. Four years later, those reasons for caution still exist, with a few new ones added. Please take a few minutes to read Dr. Haug’s letter to the editor of […]
Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard®
Philippe Halfon,1,2 Sophie Ravet,3 Hacène Khiri,1 Guillaume Penaranda,1,2,3 and Carole Lefoll2 1 Laboratoire Alphabio, Marseille, France 2 Hopital Ambroise Paré, Marseille, France 3 CDL Pharma, Marseille, France Corresponding author email: philippe.halfon@alphabio.fr This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited. Abstract We report the case of a 19-year-old woman who received a complete vaccine […]
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 60
- Next Page »